Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents

The risk of hepatocellular carcinoma recurrence is universal regardless of the treatment modality applied, and secondary prevention is still an unmet issue even though the elimination of hepatitis C (HCV) with direct antiviral agents (DAAs) was expected to be one of the new options. Unfortunately, t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Viruses
Asıl Yazarlar: Sanduzzi-Zamparelli, Marco, Boix, Loreto, Leal, Cassia, Reig, María
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6563506/
https://ncbi.nlm.nih.gov/pubmed/31052463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11050406
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller